Prostate Cancer Diagnostics Services For Clinical Medicine
-
Manufactured by Soteria Medical BVbased in NETHERLANDS
Prostate cancer is the most common cancer, other than non-melanoma skin cancer, and the second leading cause of cancer-related death in men in the United States. Prostate cancer incidence rates rose dramatically in the late 1980s, when screening with the prostate-specific antigen (PSA) test, which received initial U.S. Food and Drug Administration approval in 1986, came into wide use. It is ...
-
Manufactured by Fluxion Biosciences Incbased in USA
Fluxion provides analytical services for a diverse range of liquid biopsy and CTC applications. Our Lab Services programs enables you to get results quickly and efficiently using Fluxion’s state-of-the-art technology and laboratory facilities. You design the study, we process and analyze the samples, you get the data…it’s that ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you